UTD's Santosh D’Mello to Chair Conference on Treatment Strategies for Neurodegenerative Diseases
Dr. Santosh R. D’Mello, Professor of Molecular and Cell Biology at The University of Texas at Dallas (UTD) will chair the second annual conference on Therapeutic Strategies Against Neurodegenerative Conditions to be held on September 18 – 19. Dr. D’Mello also chaired and organized the first annual conference which was held in Boston last year.
The conference will bring together leading researchers from academia, industry, and government and will focus on the latest and most exciting research findings in the identification of novel molecular targets and the development of potential therapeutic strategies for neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke.
Neurodegenerative conditions disrupt the quality of life for patients, extracts an enormous emotional and physical strain on caregivers, and costs society billions of dollars annually. Underlying a majority of these disorders is the abnormal degeneration of neurons. While symptomatic treatments are available for many neurodegenerative disorders, drugs to reduce or prevent the neuronal loss in patients have yet to be identified. Intense research over the past few years has generated a rich and complex body of information about the mechanisms and pathophysiology of neurodegenerative conditions. This knowledge has provided the opportunity to find novel targets for drug development and resulting in the initiation of several promising clinical trials.
The conference is held under the auspices of GTCbio. You can visit the conference's online agenda for more information on the conference.
- Updated: February 6, 2006